We are live on ! Find out more
OFM

Omega Fund Management Portfolio holdings

AUM $163M
1-Year Est. Return 107.06%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+107.06%
3 Year Est. Return
+111.75%
5 Year Est. Return
+84.24%
10 Year Est. Return
+495.59%
AUM
$131M
AUM Growth
-$3.8M
Cap. Flow
-$2.09M
Cap. Flow %
-1.59%
Top 10 Hldgs %
99.55%
Holding
11
New
–
Increased
–
Reduced
3
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EDIT icon
Editas Medicine
EDIT
+$796K
2
PVLA
Palvella Therapeutics
PVLA
+$687K
3
CBAY
Cymabay Therapeutics
CBAY
+$606K

Sector Composition

Rank Sector Weight
1 Healthcare 70.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
$36.9M 28.17%
1,229,512
– –
PRTK
2
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$33.8M 25.83%
2,600,410
– –
EGLT
3
DELISTED
Egalet Corporation
EGLT
$22M 16.79%
2,889,926
– –
KYNB
4
Kyntra Bio
KYNB
$28.5M
$17M 12.99%
32,887
– –
NBRV
5
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$8.08M 6.17%
4,584
– –
EPIX
6
DELISTED
ESSA Pharma
EPIX
$4.67M 3.56%
84,848
– –
PVLA
7
Palvella Therapeutics
PVLA
$1.98B
$3.38M 2.58%
23,112
-5,173
-18% -$687K
TARA icon
8
Protara Therapeutics
TARA
$226M
$2.33M 1.78%
6,250
– –
DRNA
9
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.31M 1%
223,457
– –
EDIT icon
10
Editas Medicine
EDIT
$399M
$892K 0.68%
66,162
-38,846
-37% -$796K
CBAY
11
DELISTED
Cymabay Therapeutics
CBAY
$585K 0.45%
301,477
-304,623
-50% -$606K

Similar funds

HCCM
Hudson Canyon Capital Management New York $163M AUM 33.71% 1-Year Est. Return
PBO
Peoples Bank (Ohio) Marietta, Ohio $163M AUM 18.72% 1-Year Est. Return
PCR
Potrero Capital Research San Francisco, California $163M AUM 79.07% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
IVGAI
Index Venture Growth Associates IV St. Helier, Jersey $163M AUM 54.88% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
TCGDR
TB Capital Gestao de Recursos Rio De Janeiro $163M AUM 20.86% 1-Year Est. Return
IPWA
International Private Wealth Advisors San Diego, California $163M AUM 16.99% 1-Year Est. Return

Omega Fund Management's Q3 2016 Portfolio in Review

As of Q3 2016, Omega Fund Management held 11 positions worth $131M, down 2.8% from $135M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2016: portfolio turnover was 0%. Omega Fund Management opened no new positions and made no exits, leaving the 11-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, up from 64% a quarter earlier.

  • Omega Fund Management's biggest Q3 2016 reduction was Editas Medicine, cutting an estimated $796K.
  • Omega Fund Management's ten largest holdings make up 100% of its $131M portfolio in Q3 2016.
  • Omega Fund Management opened 0 new positions and closed 0 in Q3 2016.
  • Omega Fund Management's portfolio value fell 2.8% quarter-over-quarter to $131M.

Based on Omega Fund Management's 13F filing for Q3 2016, filed 2 Nov 2016.